feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Albino alligator Claude dies at 30

trending

College Football Playoff rankings reveal

trending

Duke defeats Florida, stays perfect

trending

Timberwolves edge Pelicans in OT

trending

Rupee crosses 90 against USD

trending

Thunder beat Warriors without Curry

trending

UConn defeats Kansas

trending

North Carolina defeats Kentucky

trending

USC Trojans defeat Oregon

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Gene Shutoff Kills Deadly TB Bacteria

Gene Shutoff Kills Deadly TB Bacteria

4 Dec

•

Summary

  • Scientists discovered a vital molecular system in TB bacteria.
  • CRISPR technology successfully shut down this essential system.
  • An experimental compound, DAT-48, also targets the system.
Gene Shutoff Kills Deadly TB Bacteria

Tuberculosis, a respiratory infection with a long history, remains a global epidemic despite being treatable. Recent scientific advancements have uncovered a critical vulnerability in the Mycobacterium tuberculosis bacterium. Researchers, led by infectious disease microbiologist Shelley Haydel, identified a molecular system named PrrAB, essential for the bacteria's survival and respiration.

Utilizing CRISPR interference technology, Haydel's team demonstrated that deactivating the PrrAB system was lethal to the bacteria in laboratory settings. This targeted approach effectively shut down the bacteria's ability to produce energy, significantly reducing their numbers. This essential system's function has positioned it as a promising therapeutic target.

Further research revealed that an experimental compound, Diarylthiazole-48 (DAT-48), also inhibits the PrrAB pathway. Combining DAT-48 with existing TB drugs or CRISPR repression showed enhanced effectiveness. While human trials are pending, these findings represent a significant step towards potentially eradicating tuberculosis.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
PrrAB is a molecular system identified in tuberculosis bacteria that is essential for their respiration and energy production, making it a potential therapeutic target.
Shelley Haydel's team used CRISPR interference to repress the essential PrrAB system in Mycobacterium tuberculosis, leading to the bacteria's death.
DAT-48 is an experimental compound that inhibits the PrrAB pathway and has shown potential in combination with other treatments against tuberculosis bacteria.

Read more news on

Healthside-arrow

You may also like

FDA's New Gene Therapy Pathway: A Game Changer?

1 Dec • 20 reads

article image

Teen CRISPR Breakthrough for Early Lyme Detection

1 Dec • 29 reads

article image

New Flu Strain Threatens Holiday Travel Immunity

28 Nov • 46 reads

article image

Antibiotics Losing Power: Superbugs Rise!

24 Nov • 55 reads

article image

Avian Flu Threatens Welsh Poultry Farmer's Livelihood

24 Nov • 59 reads

article image